NWF Advisory Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.75M Sell
12,659
-1,002
-7% -$222K 0.31% 66
2025
Q4
$3.12M Buy
13,661
+693
+5% +$158K 0.35% 63
2025
Q3
$3M Sell
12,968
-536
-4% -$109K 0.33% 70
2025
Q2
$2.51M Buy
13,504
+3,939
+41% +$732K 0.3% 69
2025
Q1
$2M Sell
9,565
-1,407
-13% -$274K 0.28% 69
2024
Q4
$1.95M Buy
10,972
+1,169
+12% +$215K 0.29% 59
2024
Q3
$1.94M Buy
9,803
+712
+8% +$133K 0.28% 71
2024
Q2
$1.56M Buy
9,091
+383
+4% +$63.4K 0.25% 70
2024
Q1
$1.59M Buy
8,708
+32
+0.4% +$5.51K 0.26% 72
2023
Q4
$1.34M Sell
8,676
-2,491
-22% -$363K 0.27% 70
2023
Q3
$1.66M Sell
11,167
-85
-0.8% -$12.5K 0.39% 53
2023
Q2
$1.52M Hold
11,252
0.35% 56
2023
Q1
$1.52M Buy
+11,252
New +$1.72M 0.35% 56

Other funds holding ABBV

NWF Advisory Services's ABBV Position: Q1 2026 in Review

NWF Advisory Services reduced its AbbVie (ABBV) stake by 7.3% in Q1 2026, selling an estimated $222K and leaving 12,659 shares worth $2.75M. The position accounts for 0.31% of the portfolio, ranked #66.

NWF Advisory Services first reported a position in ABBV in Q1 2023 and has held it in 13 quarters since. The position peaked at $3.12M in Q4 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • NWF Advisory Services held 12,659 shares of AbbVie worth $2.75M as of Q1 2026.
  • NWF Advisory Services sold 1,002 AbbVie shares in Q1 2026, an estimated $222K.
  • AbbVie made up 0.31% of NWF Advisory Services's portfolio in Q1 2026, its #66 holding.
  • NWF Advisory Services first reported a position in AbbVie in Q1 2023 and has held it in 13 quarters since.
  • NWF Advisory Services's AbbVie position peaked at $3.12M in Q4 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on NWF Advisory Services's 13F filing for Q1 2026, filed 4 May 2026.